These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30612568)

  • 1. Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study.
    Chang J; Lin G; Ye M; Tong D; Zhao J; Zhu D; Yu Q; Zhang W; Li W
    BMC Cancer; 2019 Jan; 19(1):15. PubMed ID: 30612568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy.
    Tuncel T; Ozgun A; Emirzeoglu L; Celik S; Bilgi O; Karagoz B
    Asian Pac J Cancer Prev; 2014; 15(15):6421-3. PubMed ID: 25124636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
    Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
    Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
    Barth DA; Riedl JM; Posch F; Smolle MA; Kasparek AK; Niedrist T; Szkandera J; Stöger H; Pichler M; Stotz M; Gerger A
    Clin Transl Oncol; 2019 Aug; 21(8):1034-1043. PubMed ID: 30671731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated mean platelet volume predicts poor prognosis in colorectal cancer.
    Li N; Yu Z; Zhang X; Liu T; Sun YX; Wang RT; Yu KJ
    Sci Rep; 2017 Aug; 7(1):10261. PubMed ID: 28860547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
    Zhang F; Chen Z; Wang P; Hu X; Gao Y; He J
    Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.
    Baranyai Z; Krzystanek M; Jósa V; Dede K; Agoston E; Szász AM; Sinkó D; Szarvas V; Salamon F; Eklund AC; Szállási Z; Jakab F
    Thromb Haemost; 2014 Mar; 111(3):483-90. PubMed ID: 24285160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer.
    Matsuda A; Yamada T; Matsumoto S; Sakurazawa N; Kawano Y; Shinozuka E; Sekiguchi K; Suzuki H; Yoshida H
    Anticancer Res; 2019 Aug; 39(8):4343-4350. PubMed ID: 31366528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.
    Cruz-Ramos M; Del Puerto-Nevado L; Zheng B; López-Bajo R; Cebrian A; Rodríguez-Remirez M; García-García L; Solanes-Casado S; García-Foncillas J
    J Geriatr Oncol; 2019 Sep; 10(5):742-748. PubMed ID: 30327283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma.
    Kilincalp S; Çoban Ş; Akinci H; Hamamcı M; Karaahmet F; Coşkun Y; Üstün Y; Şimşek Z; Erarslan E; Yüksel İ
    Eur J Cancer Prev; 2015 Jul; 24(4):328-33. PubMed ID: 25304028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.
    You J; Zhu GQ; Xie L; Liu WY; Shi L; Wang OC; Huang ZH; Braddock M; Guo GL; Zheng MH
    Oncotarget; 2016 May; 7(18):25516-27. PubMed ID: 27027440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer.
    Inagaki N; Kibata K; Tamaki T; Shimizu T; Nomura S
    Lung Cancer; 2014 Jan; 83(1):97-101. PubMed ID: 24189108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
    Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
    Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis.
    Huang XZ; Chen WJ; Zhang X; Wu CC; Zhang CY; Sun SS; Wu J
    Dis Markers; 2017; 2017():1053125. PubMed ID: 28539688
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Characteristics of Colorectal Cancer Patients in terms of Selected Platelet Indices.
    Copija A; Nowakowska-Zajdel E; Janion K; Walkiewicz K
    Dis Markers; 2020; 2020():6145604. PubMed ID: 33133303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean platelet volume/platelet count ratio in colorectal cancer: a retrospective clinical study.
    Wu YY; Zhang X; Qin YY; Qin JQ; Lin FQ
    BMC Cancer; 2019 Apr; 19(1):314. PubMed ID: 30947696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
    Gao L; Zhang H; Zhang B; Zhang L; Wang C
    Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer.
    Mahsuni Sevinc M; Riza Gunduz U; Kinaci E; Armagan Aydin A; Bayrak S; Umar Gursu R; Gunduz S
    J BUON; 2016; 21(5):1153-1157. PubMed ID: 27837617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.